These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33370502)

  • 61. Impact of delayed graft function and acute rejection on kidney graft survival.
    Gjertson DW
    Clin Transpl; 2000; ():467-80. PubMed ID: 11512359
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Recipient pre-existing chronic hypotension is associated with delayed graft function and inferior graft survival in kidney transplantation from elderly donors.
    Dolla C; Mella A; Vigilante G; Fop F; Allesina A; Presta R; Verri A; Gontero P; Gobbi F; Balagna R; Giraudi R; Biancone L
    PLoS One; 2021; 16(4):e0249552. PubMed ID: 33819285
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical research and social status investigation for donor and recipient of living-related kidney transplant.
    Xue W; Tian P; Ding X; Pan X; Yan H; Hou J; Feng X; Xiang H; Tian X; Ren L; Zheng J; Li S
    Int Urol Nephrol; 2013 Feb; 45(1):239-49. PubMed ID: 22893495
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The effect of cold ischemia time on delayed graft function and acute rejection in kidney transplantation.
    Sert I; Colak H; Tugmen C; Dogan SM; Karaca C
    Saudi J Kidney Dis Transpl; 2014 Sep; 25(5):960-6. PubMed ID: 25193891
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The risk of allograft failure and the survival benefit of kidney transplantation are complicated by delayed graft function.
    Gill J; Dong J; Rose C; Gill JS
    Kidney Int; 2016 Jun; 89(6):1331-6. PubMed ID: 27165823
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Duration of delayed graft function and its impact on graft outcomes in deceased donor kidney transplantation.
    Budhiraja P; Reddy KS; Butterfield RJ; Jadlowiec CC; Moss AA; Khamash HA; Kodali L; Misra SS; Heilman RL
    BMC Nephrol; 2022 Apr; 23(1):154. PubMed ID: 35440023
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Incidence, risk factors, and outcomes of delayed graft function in deceased donor kidney transplantation in a Brazilian center.
    Helfer MS; Vicari AR; Spuldaro F; Gonçalves LF; Manfro RC
    Transplant Proc; 2014; 46(6):1727-9. PubMed ID: 25131022
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Delayed graft function: predictive factors and impact on outcome in living-related kidney transplantations.
    Senel FM; Karakayali H; Moray G; Haberal M
    Ren Fail; 1998 Jul; 20(4):589-95. PubMed ID: 9713877
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Living-donor kidney transplant in T-cell and B-cell flow cytometry crossmatch-positive patients.
    Terasaka S; Kitada H; Okabe Y; Kawanami S; Noguchi H; Miyamoto K; Tsuchimoto A; Masutani K; Tanaka M
    Exp Clin Transplant; 2014 Jun; 12(3):227-32. PubMed ID: 24907723
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of Physical Crossmatch and Virtual Crossmatch to Identify Preexisting Donor-Specific Human Leukocyte Antigen (HLA) Antibodies and Outcome Following Kidney Transplantation.
    Peng B; Zhuang Q; Yu M; Li J; Liu Y; Zhu L; Ming Y
    Med Sci Monit; 2019 Feb; 25():952-961. PubMed ID: 30712055
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Delayed Graft Function, Predictive Factors, and 7-Year Outcome of Deceased Donor Kidney Transplant Recipients With Different Immunologic Profiles.
    Quintella AHDS; Lasmar MF; Fabreti-Oliveira RA; Nascimento E
    Transplant Proc; 2018 Apr; 50(3):737-742. PubMed ID: 29661426
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Delayed graft function and the risk of acute rejection in the modern era of kidney transplantation.
    Wu WK; Famure O; Li Y; Kim SJ
    Kidney Int; 2015 Oct; 88(4):851-8. PubMed ID: 26108067
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Living donor postnephrectomy kidney function and recipient graft loss: A dose-response relationship.
    Holscher CM; Ishaque T; Garonzik Wang JM; Haugen CE; DiBrito SR; Jackson KR; Muzaale AD; Massie AB; Al Ammary F; Ottman SE; Henderson ML; Segev DL
    Am J Transplant; 2018 Nov; 18(11):2804-2810. PubMed ID: 30086198
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The risk factors of delayed graft function and comparison of clinical outcomes after deceased donor kidney transplantation: single-center study.
    Jung GO; Yoon MR; Kim SJ; Sin MJ; Kim EY; Moon JI; Kim JM; Choi GS; Kwon CH; Cho JW; Lee SK
    Transplant Proc; 2010 Apr; 42(3):705-9. PubMed ID: 20430152
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Better graft outcomes from offspring donor kidneys among living donor kidney transplant recipients in the United States.
    Holscher CM; Luo X; Massie AB; Purnell TS; Garonzik Wang JM; Bae S; Henderson ML; Al Ammary F; Ottman SE; Segev DL
    Am J Transplant; 2019 Jan; 19(1):269-276. PubMed ID: 30253051
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Presence of CD163
    van Alem CMA; Bank JR; de Vries DK; Bajema IM; Mallat MJK; de Fijter JW; Rotmans JI; van Kooten C
    Transpl Immunol; 2022 Dec; 75():101714. PubMed ID: 36108808
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death.
    Fidler SJ; Irish AB; Lim W; Ferrari P; Witt CS; Christiansen FT
    Transpl Immunol; 2013 Jun; 28(4):148-53. PubMed ID: 23665534
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of delayed graft function on longer-term outcomes after kidney transplantation from donation after circulatory death donors in the United Kingdom: A national cohort study.
    Phillips BL; Ibrahim M; Greenhall GHB; Mumford L; Dorling A; Callaghan CJ
    Am J Transplant; 2021 Oct; 21(10):3346-3355. PubMed ID: 33756062
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Posttransplant Outcomes for cPRA-100% Recipients Under the New Kidney Allocation System.
    Jackson KR; Holscher C; Motter JD; Desai N; Massie AB; Garonzik-Wang J; Alachkar N; Segev DL
    Transplantation; 2020 Jul; 104(7):1456-1461. PubMed ID: 31577673
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Luminex Solid-Phase Crossmatch for De Novo Donor-Specific Antibodies in Living-Donor Related Transplants.
    Mehrotra S; Sharma RK; Mayya M; Gupta A; Prasad N; Kaul A; Bhadauria DS
    Exp Clin Transplant; 2017 Aug; 15(4):394-399. PubMed ID: 28447925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.